利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

24 条记录 (耗时 0.041 秒)

    Process for producing 2-carbon-substituted carbapenem derivatives
    3.
    发明授权
    Process for producing 2-carbon-substituted carbapenem derivatives 失效
    制备2-碳取代的碳代青霉烯衍生物的方法

    公开(公告)号：US5258509A

    公开(公告)日：1993-11-02

    申请号：US989150

    申请日：1992-12-11

    申请人： Susumu Nakagawa ,  Yoshiaki Kato ,  Hiroshi Fukatsu

    发明人： Susumu Nakagawa ,  Yoshiaki Kato ,  Hiroshi Fukatsu

    IPC分类号： C07D477/02 ,  C07D477/14 ,  C07D487/04

    CPC分类号： C07D477/14 ,  C07D477/02

    摘要： A process for producing a 2-(unsubstituted or carbon-substituted)-1-carbapen-2-em-3-carboxylic acid derivative, which comprises reacting a 2-trifluoromethanesulfonyloxy-1-carbapen-2-em-3-carboxylic acid derivative or the 1-carbapen-2-em-3-carboxylic acid derivative derived from a 2-oxo-1-carbapenam-3-carboxylic acid derivative and trifluoromethanesulfonic anhydride, and a stannane derivative in an inert solvent in the presence of a palladium compound and a salt.

    摘要翻译： 2-（未取代或碳取代的）-1-碳代青霉-2-烯-3-羧酸衍生物的制备方法，其包括使2-三氟甲磺酰氧基-1-碳代青霉-2-烯-3-羧酸衍生物 或衍生自2-氧代-1-碳青霉烯-3-羧酸衍生物的1-碳代青霉-2-烯-3-羧酸衍生物和三氟甲磺酸酐，以及在惰性溶剂中在钯化合物存在下的锡烷衍生物 和盐。

    Piperidylthiocarbapenem derivatives
    4.
    发明授权
    Piperidylthiocarbapenem derivatives 失效
    哌嗪基溴衍生物

    公开(公告)号：US5153188A

    公开(公告)日：1992-10-06

    申请号：US561846

    申请日：1990-08-02

    申请人： Susumu Nakagawa ,  Shinji Kato ,  Hiroshi Fukatsu

    发明人： Susumu Nakagawa ,  Shinji Kato ,  Hiroshi Fukatsu

    IPC分类号： C07D477/00 ,  A61K31/397 ,  A61K31/40 ,  A61P31/04 ,  C07D211/54 ,  C07D211/60 ,  C07D477/20

    CPC分类号： C07D477/20 ,  C07D211/54 ,  C07D211/60 ,  Y02P20/55

    摘要： A compound represented by the general formula (I): ##STR1## wherein R.sup.1 is a hydrogen atom or a methyl group; R.sup.2 and R.sup.3, which may be the same or different, each represents a hydrogen atom or a lower alkyl group, or taken together with the adjacent nitrogen atom, jointly represent a heterocyclic group selected from the group consisting of an aziridinyl group, an azetidinyl group, a pyrrolidinyl group, a piperidino group, a piperazinyl group, a 4-lower alkylpiperazinyl group, a morpholino group and a thiomorpholino group; and A is a single bond, a lower alkylene group, a lower alkenylene group or a lower alkynylene group; or a pharmaceutically acceptable salt or ester thereof.The compound of the general formula (I) and their salts or esters exhibit excellent antibacterial activity.

    Workpiece conveying apparatus
    6.
    发明授权
    Workpiece conveying apparatus 失效

    公开(公告)号：US4574941A

    公开(公告)日：1986-03-11

    申请号：US599866

    申请日：1984-04-13

    申请人： Eiji Tsuge ,  Taminori Yanagisawa ,  Takaharu Yamaguchi ,  Hiroshi Fukatsu

    发明人： Eiji Tsuge ,  Taminori Yanagisawa ,  Takaharu Yamaguchi ,  Hiroshi Fukatsu

    IPC分类号： B21D43/04 ,  B21D43/10 ,  B65G47/91 ,  B65G25/02

    CPC分类号： B21D43/105 ,  B65G47/914 ,  Y10S414/13 ,  Y10T74/18072

    摘要： A workpiece conveying apparatus for a working machine including provided with a slider rail arranged vertically on the body of the workpiece conveying apparatus, a drive source, a parallel link consisting of the slider link which is fitted crossing at right angles to and slidably in said slider rail, a slider arm, a lower slider link carrying a work holder and a sub arm and being connected rotatably with each other, a rocking lever being connected to the middle portion of the slider arm rotatably and rocked by a driving mechanism at a predetermined angle, whereby the work holder can convey a workpiece into or out of the specified position along with the intentional locus settled selectively so as to reduce the operating range, and keep a continuous working operation of the working machine, resulting in the durability of the working machine.

    Medical image diagnostic system for creating order information
    8.
    发明授权
    Medical image diagnostic system for creating order information 有权
    用于创建订单信息的医疗图像诊断系统

    公开(公告)号：US08046240B2

    公开(公告)日：2011-10-25

    申请号：US11563106

    申请日：2006-11-24

    申请人： Hiroshi Fukatsu ,  Muneyasu Kazuno ,  Akira Iwasa

    发明人： Hiroshi Fukatsu ,  Muneyasu Kazuno ,  Akira Iwasa

    IPC分类号： G06Q10/00

    CPC分类号： G06Q50/24 ,  G06F19/00 ,  G06F19/321 ,  G06Q50/22 ,  G16H15/00

    摘要： In issuing an order, a medical image diagnostic system acquires order issuance support information on the basis of a reference report or a reference image, which an order issuer uses as a basis of order creation. The medical image diagnostic system classifies the order issuance support information on the basis of a table and presents the order issuance support information using a predetermined order issuance support screen. For example, the order issuer selects desired conditions from the order issuance support screen presented to perform order issuance based on the reference report or the like.

    摘要翻译： 在发布订单时，医用图像诊断系统基于订单发行者用作订单创建的基础的参考报告或参考图像来获取订单发行支持信息。 医疗图像诊断系统基于表格对订单发行支持信息进行分类，并使用预定的订单发行支持画面呈现订单发行支持信息。 例如，订单发行者基于参考报告等从所呈现的订单发行支持屏幕中选择所需条件以执行订单发行。

    Cyclic amidinylthiocarbapenem derivatives
    9.
    发明授权
    Cyclic amidinylthiocarbapenem derivatives 失效
    环丙氨基噻吩衍生物

    公开(公告)号：US5100888A

    公开(公告)日：1992-03-31

    申请号：US549574

    申请日：1990-07-06

    申请人： Susumu Nakagawa ,  Yoshiaki Kato ,  Hiroshi Fukatsu

    发明人： Susumu Nakagawa ,  Yoshiaki Kato ,  Hiroshi Fukatsu

    IPC分类号： C07D477/00 ,  A61K31/397 ,  A61K31/40 ,  A61P31/04 ,  C07D207/24 ,  C07D477/20

    CPC分类号： C07D477/20 ,  C07D207/24 ,  Y02P20/55

    摘要： A compound represented by formula (I): ##STR1## wherein R.sup.1 represents a hydrogen atom or a methyl group; R.sup.2 and R.sup.3, which may be the same or different, each represents a hydrogen atom or a lower alkyl group; and R.sup.4 represents a carboxyl group, a lower alkoxycarbonyl group, a carbamoyl group, a lower alkylcarbamoyl group, a di-lower alkylcarbamoyl group, or a carbonyl group substituted with a heterocyclic group selected from the group consisting of an aziridinyl group, an azetidinyl group, a pyrrolidinyl group, a piperidino group, a morpholino group, a thio-morpholino group, a piperazinyl group, and a 4-lower alkyl-1-piperazinyl group, or a pharmaceutically acceptable salt or ester thereof. The compound of formula (I) and their salts or esters exhibit excellent antibacterial activity.